Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catalyst Pharmaceuticals (CPRX) Other Working Capital Changes: 2009-2024

Historic Other Working Capital Changes for Catalyst Pharmaceuticals (CPRX) over the last 14 years, with Dec 2024 value amounting to $11,124.

  • Catalyst Pharmaceuticals' Other Working Capital Changes rose 229.64% to $6.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.7 million, marking a year-over-year increase of 120.24%. This contributed to the annual value of $11,124 for FY2024, which is 99.81% down from last year.
  • As of FY2024, Catalyst Pharmaceuticals' Other Working Capital Changes stood at $11,124, which was down 99.81% from $5.8 million recorded in FY2023.
  • In the past 5 years, Catalyst Pharmaceuticals' Other Working Capital Changes registered a high of $5.8 million during FY2023, and its lowest value of -$4.0 million during FY2021.
  • Moreover, its 3-year median value for Other Working Capital Changes was $807,000 (2022), whereas its average is $2.2 million.
  • Its Other Working Capital Changes has fluctuated over the past 5 years, first plummeted by 200.00% in 2021, then surged by 617.72% in 2023.
  • Yearly analysis of 5 years shows Catalyst Pharmaceuticals' Other Working Capital Changes stood at $4.0 million in 2020, then slumped by 200.00% to -$4.0 million in 2021, then soared by 120.29% to $807,000 in 2022, then soared by 617.72% to $5.8 million in 2023, then slumped by 99.81% to $11,124 in 2024.